{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T01:21:10Z","timestamp":1792113670596,"version":"4.4.0"},"reference-count":37,"publisher":"Cambridge University Press (CUP)","issue":"2","license":[{"start":{"date-parts":[[2003,10,9]],"date-time":"2003-10-09T00:00:00Z","timestamp":1065657600000},"content-version":"unspecified","delay-in-days":69,"URL":"https:\/\/www.cambridge.org\/core\/terms"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Parasitology"],"published-print":{"date-parts":[[2003,8]]},"DOI":"10.1017\/s0031182003003457","type":"journal-article","created":{"date-parts":[[2003,8,15]],"date-time":"2003-08-15T09:53:22Z","timestamp":1060941202000},"page":"107-114","source":"Crossref","is-referenced-by-count":27,"title":["Prophylactic potential of autoclaved <i>Leishmania donovani<\/i> with BCG against experimental visceral leishmaniasis"],"prefix":"10.1017","volume":"127","author":[{"given":"J. K.","family":"SRIVASTAVA","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"MISRA","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"SHARMA","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.","family":"SRIVASTAVA","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"NAIK","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"DUBE","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"56","published-online":{"date-parts":[[2003,10,9]]},"reference":[{"key":"S0031182003003457_ref007","doi-asserted-by":"crossref","unstructured":"CARVALHO, E. M. , BACELLAR, O. , BROWNELL, C. , REGIS, T. , COFFMAN, R. L. & REED, S. G. (1994).Restoration of IFN-\u03b3 production and lymphocyte proliferation in visceral leishmaniasis.Journal of Immunology 152, 5949\u20135956.","DOI":"10.4049\/jimmunol.152.12.5949"},{"key":"S0031182003003457_ref020","doi-asserted-by":"publisher","DOI":"10.1016\/0035-9203(82)90095-5"},{"key":"S0031182003003457_ref021","doi-asserted-by":"publisher","DOI":"10.1098\/rstb.1984.0111"},{"key":"S0031182003003457_ref002","unstructured":"ALEXANDER, J. (1988).Chemotherapy and immune response. In Leishmaniasis: The Current Status and New Strategies for Control: NATO-ASI Series A., Vol. 163 (ed. Hart, D. T. ),pp. 839\u2013843.Plenum Press, New York."},{"key":"S0031182003003457_ref014","doi-asserted-by":"publisher","DOI":"10.1016\/0169-4758(89)90143-9"},{"key":"S0031182003003457_ref027","doi-asserted-by":"publisher","DOI":"10.1080\/00034983.1985.11811917"},{"key":"S0031182003003457_ref015","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.69.1.245-251.2001"},{"key":"S0031182003003457_ref035","unstructured":"THAKUR, C. P. (1993).Kala-azar background paper, Status paper on kala-azar in Bihar.Core Group Discussion on Kala-Azar Control in India. 24\u201325 September, 1993."},{"key":"S0031182003003457_ref001","doi-asserted-by":"publisher","DOI":"10.1126\/science.7904381"},{"key":"S0031182003003457_ref034","doi-asserted-by":"publisher","DOI":"10.1086\/516526"},{"key":"S0031182003003457_ref010","doi-asserted-by":"publisher","DOI":"10.1016\/0035-9203(90)90319-A"},{"key":"S0031182003003457_ref033","unstructured":"SHARMA, P. , ANURADHA , SRIVASTAVA, J. K. , GUPTA, H. P. & KATIYAR, J. C. (1998).Immunization against Leishmania donovani: efficacy of Mycobacterium habana in combination with killed promastigotes in hamsters.Current Science 70, 770\u2013773."},{"key":"S0031182003003457_ref013","doi-asserted-by":"publisher","DOI":"10.1084\/jem.181.5.1615"},{"key":"S0031182003003457_ref009","doi-asserted-by":"crossref","unstructured":"CASTES, M. , BLACKWELL, J. , TRUJILLO, D. , FORMICA, S. , CABRERA, M. , ZORRILLA, G. , RODAS, A. , CASTELLANOS, P. L. & CONVIT, J. (1994).Immune response in healthy volunteers vaccinated with killed leishmanial promastigotes plus BCG I. Skin-test reactivity T-cell prolfieration and interferon-\u03b3 production.Vaccine 12, 1041\u20131051.","DOI":"10.1016\/0264-410X(94)90342-5"},{"key":"S0031182003003457_ref008","doi-asserted-by":"publisher","DOI":"10.1172\/JCI112209"},{"key":"S0031182003003457_ref012","doi-asserted-by":"publisher","DOI":"10.1016\/S0001-706X(99)00007-8"},{"key":"S0031182003003457_ref024","doi-asserted-by":"crossref","unstructured":"LAGRANDERIE, M. R. , BALAZUC, A. M. , DERIAUD, E. , LECLERC, C. D. & GHEORGHIU, M. (1996).Comparison of immune responses of mice immunized with five different Mycobacterium bovis BCG vaccine strains.Infection and Immunity 64, 1\u20139.","DOI":"10.1128\/iai.64.1.1-9.1996"},{"key":"S0031182003003457_ref011","doi-asserted-by":"crossref","unstructured":"DUBE, A. , SHARMA, P. , SRIVASTAVA, J. K. , MISRA, A. & KATIYAR, J. C. (1998).Vaccination of langur monkeys (Presbytis entellus) against Leishmania donovani with autoclaved L. major plus BCG.Parasitology 116, 219\u2013221.","DOI":"10.1017\/S0031182097002175"},{"key":"S0031182003003457_ref022","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.316.7139.1200"},{"key":"S0031182003003457_ref029","doi-asserted-by":"publisher","DOI":"10.1038\/icb.1987.44"},{"key":"S0031182003003457_ref030","doi-asserted-by":"crossref","unstructured":"MOMENI, A. Z. , JALAYER, T. , EMAMJOMEH, M. , KHAMESIPOUR, A. , ZICKER, F. , GHASSEMI, R. L. , DOWLATI, Y. , SHARIFI, I. , AMINJAVAHERI, M. , SHAFIEI, A. , ALIMOHAMMADIAN, M. H. , FESHARKI, R. H. , NASSERI, K. , GODAL, T. , SMITH, P. G. & MODABBER, F. (1998).A randomised, double-blind controlled trial of a killed Leishmania major plus BCG against zoonotic cutaneous leishmaniasis in Iran.Vaccine 17, 466\u2013472.","DOI":"10.1016\/S0264-410X(98)00220-5"},{"key":"S0031182003003457_ref023","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(00)03128-7"},{"key":"S0031182003003457_ref016","doi-asserted-by":"publisher","DOI":"10.1006\/expr.1996.4117"},{"key":"S0031182003003457_ref003","doi-asserted-by":"crossref","unstructured":"ARMIJOS, R. X. , WEIGEL, M. M. , AVILES, H. , MALDONADO, R. & RACINES, J. (1998).Field trial of a vaccine against New World Cutaneous leishmaniasis in an at-risk child population. Safety, immunogencity, and efficacy during the first 12 months of follow-up.Journal of Infectious Diseases 177, 1352\u20131357.","DOI":"10.1086\/515265"},{"key":"S0031182003003457_ref017","unstructured":"GREENBLATT, C. L. (1980).The present and future of vaccination for cutaneous leishmaniasis. In New Developments with Human and Veterinary Vaccines Progress in Clinical and Biological Research 47 ,(ed. Mizrahi, A. , Hertman, I. , Klingerg, M. A. & Kohn, A. ),pp. 259\u2013285.Alan R Liss, New York, New York."},{"key":"S0031182003003457_ref019","doi-asserted-by":"publisher","DOI":"10.1128\/CMR.14.2.229-243.2001"},{"key":"S0031182003003457_ref026","doi-asserted-by":"publisher","DOI":"10.2174\/1568008023340631"},{"key":"S0031182003003457_ref004","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/154.6.1003"},{"key":"S0031182003003457_ref037","unstructured":"WHO(1998).Advances in battle against leishmaniasis.TDR News 34, 1\u20137."},{"key":"S0031182003003457_ref006","doi-asserted-by":"publisher","DOI":"10.1007\/PL00000824"},{"key":"S0031182003003457_ref032","doi-asserted-by":"publisher","DOI":"10.4269\/ajtmh.1978.27.1079"},{"key":"S0031182003003457_ref005","doi-asserted-by":"publisher","DOI":"10.1017\/S0031182000075375"},{"key":"S0031182003003457_ref028","doi-asserted-by":"crossref","unstructured":"MISRA, A. , DUBE, A. , SHARMA, P. , SRIVASTAVA, J. K. , SRIVASTAVA, B. , KATIYAR, J. C. & NAIK, S. (2001).Successful vaccination against Leishmania donovani infection in Indian langurs using Alum-precipitated autoclaved L. major (ALM) with BCG.Vaccine 19, 3485\u20133492.","DOI":"10.1016\/S0264-410X(01)00058-5"},{"key":"S0031182003003457_ref031","doi-asserted-by":"crossref","unstructured":"NURIT, R. & JAFFE, C. L. (1993).Pure protein from Leishmania donovani protects mice against both cutaneous and visceral leishmaniasis.Journal of Immunology 150, 2322\u20132331.","DOI":"10.4049\/jimmunol.150.6.2322"},{"key":"S0031182003003457_ref025","doi-asserted-by":"crossref","unstructured":"LOWRY, O. H. , ROSEBROUGH, N. J. , FARR, A. L. & RANDALL, R. J. (1951).Protein measurement with folin-phenol reagent.Journal of Biological Chemistry 193, 265\u2013275.","DOI":"10.1016\/S0021-9258(19)52451-6"},{"key":"S0031182003003457_ref018","unstructured":"GUPTA, S. , SRIVASTAVA, J. K. , RAY, S. , CHANDRA, R. , SRIVASTAVA, V. K. & KATIYAR, J. C. (1993).Evaluation of enzyme linked immunosorbant assay in the diagnosis of kala-azar in Malda district (West Bengal).Indian Journal of Medical Research 97, 242\u2013246."},{"key":"S0031182003003457_ref036","unstructured":"VOLLER, A. , BIDWELL, D. E. & BARTLETT, A. (1979). The Enzyme-Linked Immunosorbent Assay (ELISA): a Guide with Abstracts of Microplate Application .Fileroline Press, Guernsey, Channel Islands."}],"container-title":["Parasitology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cambridge.org\/core\/services\/aop-cambridge-core\/content\/view\/S0031182003003457","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,20]],"date-time":"2025-06-20T21:11:06Z","timestamp":1750453866000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cambridge.org\/core\/product\/identifier\/S0031182003003457\/type\/journal_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,8]]},"references-count":37,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2003,10]]}},"alternative-id":["S0031182003003457"],"URL":"https:\/\/doi.org\/10.1017\/s0031182003003457","relation":{},"ISSN":["0031-1820","1469-8161"],"issn-type":[{"value":"0031-1820","type":"print"},{"value":"1469-8161","type":"electronic"}],"subject":[],"published":{"date-parts":[[2003,8]]}}}